Taibidi Pharmaceutical Technology(shijiazhuang) Co.,ltd.

This early-stage study tests a new drug called TPD3310 in about 112 people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for any early signs that the drug can shrink tumors. Participants will receive th…